PMC:7211620 / 9990-10239
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T35","span":{"begin":58,"end":63},"obj":"Body_part"}],"attributes":[{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T26","span":{"begin":58,"end":63},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T77","span":{"begin":17,"end":26},"obj":"Disease"},{"id":"T78","span":{"begin":31,"end":44},"obj":"Disease"},{"id":"T79","span":{"begin":230,"end":243},"obj":"Disease"}],"attributes":[{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T82","span":{"begin":52,"end":54},"obj":"Chemical"}],"attributes":[{"id":"A82","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T79","span":{"begin":0,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"311","span":{"begin":17,"end":26},"obj":"Species"},{"id":"312","span":{"begin":52,"end":54},"obj":"Chemical"},{"id":"314","span":{"begin":31,"end":44},"obj":"Disease"},{"id":"315","span":{"begin":230,"end":243},"obj":"Disease"}],"attributes":[{"id":"A311","pred":"tao:has_database_id","subj":"311","obj":"Tax:11308"},{"id":"A312","pred":"tao:has_database_id","subj":"312","obj":"MESH:D005839"},{"id":"A314","pred":"tao:has_database_id","subj":"314","obj":"MESH:D001228"},{"id":"A315","pred":"tao:has_database_id","subj":"315","obj":"MESH:D001228"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}
2_test
{"project":"2_test","denotations":[{"id":"32395423-30076119-68941096","span":{"begin":245,"end":247},"obj":"30076119"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}